Allergan oral migraine drug succeeds in study

Allergan oral migraine drug succeeds in study(Reuters) – Allergan Plc said on Monday its oral migraine drug met the main goal across all doses in a study, with a statistically significant reduction in monthly headache days in patients with episodic migraine. The treatment, atogepant, belongs to a class of migraine drugs also being developed by Eli Lilly and Alder Biopharmaceuticals that target a protein associated with pain signaling called calcitonin gene-related peptide (CGRP). Last month, the U.S. Food and Drug Administration approved Amgen Inc’s CGRP treatment Aimovig, which is self injected monthly and will have a list price of $6,900 a year, or $575 a month.


Source: Yahoo! News

Recall of Brock Turner judge succeeds: Voters oust Aaron Persky for sentence in sexual assault case

  1. Recall of Brock Turner judge succeeds: Voters oust Aaron Persky for sentence in sexual assault case  The Mercury News
  2. Early returns show voters backing recall of California judge for lenient sex offender sentencing  NBCNews.com
  3. Voters Favor Recalling Persky as Polls Close in California Primary  NBC Bay Area
  4. Vandalism, threats, broken friendships: The heated campaign to recall judge in Brock Turner case  Los Angeles Times
  5. Voters Are Deciding Whether To Recall Aaron Persky, Judge Who Sentenced Brock Turner  NPR
  6. Full coverage


Source: Google News